Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Nature

• Publication date

  1997-11-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/37144PMID 9389483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2

  1997cited by this paper
• X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

  1996cited by this paper
• Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

  1996cited by this paper
• BAX is required for neuronal death after trophic factor deprivation and during development.

  1996cited by this paper
• Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development.

  1996cited by this paper
• Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease.

  1996cited by this paper
• A novel nuclear structure containing the survival of motor neurons protein.

  1996cited by this paper
• Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients.

  1995cited by this paper
• A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients

  1995cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.

  1995cited by this paper
• Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes.

  1994cited by this paper
• bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS.

  1994cited by this paper
• Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.

  1993cited by this paper
• Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo.

  1992cited by this paper

• Tudor-Containing Methyl-Lysine and Methyl-Arginine Reader Proteins: Disease Implications and Chemical Tool Development.

  2024cites this paper
• Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches

  2024cites this paper
• Amino acid degradation pathway inhibitory by‐products trigger apoptosis in CHO cells

  2024cites this paper
• SMN haploinsufficiency promotes ischemia/ reperfusion‐induced AKI‐to‐CKD transition by endoplasmic reticulum stress activation

  2023cites this paper
• Cerebellar structural, astrocytic, and neuronal abnormalities in the SMNΔ7 mouse model of spinal muscular atrophy

  2023cites this paper
• Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer.

  2022cites this paper
• Mitochondrial Dysfunction in Spinal Muscular Atrophy

  2022cites this paper
• Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy (SMA) Disease Can Increase In Vitro SMN Expression

  2022cites this paper
• Spinal Muscular Atrophy: In the Challenge Lies a Solution.

  2021cites this paper
• Revisiting the role of mitochondria in spinal muscular atrophy

  2021cites this paper
• [Spinal muscular atrophy in samara region. Epidemiology, classification, prospects for health care].

  2020cites this paper
• Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma

  2020cites this paper
• Intracellular partners of fibroblast growth factors 1 and 2 - implications for functions.

  2020cites this paper
• Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients.

  2020cites this paper
• Methioninase Gene Therapy.

  2019cites this paper
• Survival Motor Neuron (SMN) Protein Insufficiency Exacerbates Renal Ischemia/Reperfusion Injury

  2019cites this paper
• Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates

  2018cites this paper
• Spinal Muscular Atrophy

  2018cites this paper
• Protective Effect of Saccharomyces boulardii on Deoxynivalenol-Induced Injury of Porcine Macrophage via Attenuating p38 MAPK Signal Pathway

  2017cites this paper
• An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy

  2016cites this paper
• Analysis of RNA metabolism in peripheral WBCs of TDP-43 KI mice identifies novel biomarkers of ALS.

  2016cites this paper
• Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy

  2016cites this paper
• Advances and challenges in developing a therapy for spinal muscular atrophy

  2015cites this paper
• Nanomolar Naloxone Attenuates Neurotoxicity Induced by Oxidative Stress and Survival Motor Neuron Protein Deficiency

  2014cites this paper
• Defining the anti-apoptotic function of the survival of motor neuron (SMN) protein and assessment of a novel therapy for the treatment of spinal muscular atrophy (SMA)

  2014cites this paper
• Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.

  2014cites this paper
• Understanding Protein–Nanoparticle Interaction: A New Gateway to Disease Therapeutics

  2014cites this paper
• Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein

  2013influential citation
• Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

  2013cites this paper
• Molecular characterization of the cancer susceptibility protein wrap53β in Cajal body formation and DNA repair

  2013cites this paper
• Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis

  2013cites this paper
• Inhibition of genotoxic stress induced apoptosis by novel TAT-fused peptides targeting PIDDosome.

  2012cites this paper
• Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.

  2012influential citation
• Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy

  2012influential citation
• Regulation of anti‐apoptotic BCL2‐proteins by non‐canonical interactions: The next step forward or two steps back?

  2012influential citation
• New insights into the pathogenesis of spinal muscular atrophy.

  2011cites this paper
• C. elegans, un outil de criblage pour la recherche de traitements contre les maladies rares

  2010cites this paper
• Screening of cell death genes with a mammalian genome-wide RNAi library.

  2010cites this paper
• Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes.

  2009cites this paper
• Bone loss in survival motor neuron (Smn−/− SMN2) genetic mouse model of spinal muscular atrophy

  2009cites this paper
• Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent

  2009cites this paper
• Pathogenesis of proximal autosomal recessive spinal muscular atrophy

  2008cites this paper
• Hypomutability at the Polyadenine Tract in SMN Intron 3 Shows the Invariability of the a‐SMN Protein Structure

  2008cites this paper
• Diseases of movement and system degenerations

  2008cites this paper
• 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.

  2008cites this paper
• Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy

  2008cites this paper
• Extracellular pH change modulates the exon 7 splicing in SMN2 mRNA.

  2008cites this paper
• Anti‐apoptotic activity of Bcl‐2 is enhanced by its interaction with RTN3

  2007cites this paper
• Histologic and transcriptional assessment of a mild SMA model

  2007cites this paper
• Stat5 constitutive activation rescues defects in spinal muscular atrophy.

  2007cites this paper
• Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis

  2007cites this paper
• Effects of Korean Mistletoe Lectin(Viscum album coloratum) on Proliferation and Cytokine Expression in Human Peripheral Blood Mononuclear Cells and T-Lymphocytes

  2007cites this paper
• Neuronal Apoptosis in Neurodegeneration

  2007influential citation
• Targeting of SMN to Cajal bodies is mediated by self-association.

  2007cites this paper
• A missense mutation in the 3-ketodihydrosphingosine reductase FVT1 as candidate causal mutation for bovine spinal muscular atrophy

  2007cites this paper
• The role of eEF1A2 in the pathogenesis of motor neurone disease in wasted mice

  2007cites this paper
• Congenital Bone Fractures in Spinal Muscular Atrophy: Functional Role for SMN Protein in Bone Remodeling

  2007cites this paper
• Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells.

  2007cites this paper
• Refined characterization of the expression and stability of the SMN gene products.

  2007cites this paper
• Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN.

  2006cites this paper
• Apoptosis induction by γ-tocotrienol in human hepatoma Hep3B cells

  2006cites this paper
• Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells.

  2006cites this paper
• Fine-mapping and candidate gene analysis of bovine spinal muscular atrophy

  2006cites this paper
• Spinal muscular atrophy: from gene to therapy.

  2006cites this paper
• Radiation hybrid mapping of the pig SMNDC1, ARPP-19 and PRO2730 genes to SSC14, SSC1 and SSC13 respectively

  2006cites this paper
• Molecular genetic investigations of histone deacetylase inhibitors as potential neurotherapeutics for autosomal recessive proximal spinal muscular atrophy (SMA)

  2006cites this paper
• Neuronal-Specific Roles of the Survival Motor Neuron Protein: Evidence From Survival Motor Neuron Expression Patterns in the Developing Human Central Nervous System

  2006cites this paper
• The Physiological Function of Beclin, a Novel BCL-2 Interacting Protein in Protein Trafficking

  2005cites this paper
• Mechanisms of apoptosis during reovirus infection.

  2005cites this paper
• Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology.

  2005cites this paper
• Genotype-Phenotype correlation of SMN locus genes in spinal muscular atrophy patients from India

  2005cites this paper
• Principles: mechanisms and modeling of synergism in cellular responses.

  2005cites this paper
• Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death.

  2005cites this paper
• Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death

  2004cites this paper
• Molecular cloning and expression of the osteoclast-stimulating-factor-like gene from the rice field eel.

  2004cites this paper
• Hereditary motor and autonomic neuronopathy 1 maps to chromosome 20q13.2-13.3.

  2004cites this paper
• Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism.

  2004cites this paper
• Apoptosis: a key in neurodegenerative disorders.

  2004cites this paper
• Aβ1-40およびAβ1-42による細胞死とその抑制遺伝子·タンパク

  2004cites this paper
• [Possible mechanisms of A beta(1-40)- or A beta(1-42)-induced cell death and their rescue factors].

  2004cites this paper
• Apoptosis in acute and chronic neurological disorders.

  2004influential citation
• Survival Motor Neuron (SMN) Protein Interacts with Transcription Corepressor mSin3A*

  2004cites this paper
• Prediction of synergism on frequency of responses in the attojoule range

  2004cites this paper
• Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.

  2004cites this paper
• Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus

  2004cites this paper
• PROTEIN INTERACTION MAPPING: USE OF OSPREY TO MAP SURVIVAL OF MOTOR NEURON PROTEIN INTERACTIONS

  2004cites this paper
• At the nucleus of the problem: nuclear proteins and disease.

  2003cites this paper
• Reovirus-Induced Alteration in Expression of Apoptosis and DNA Repair Genes with Potential Roles in Viral Pathogenesis

  2003cites this paper
• The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein.

  2003cites this paper
• Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology.

  2003cites this paper
• Downregulation of Bcl‐2 Proteins in Type I Spinal Muscular Atrophy Motor Neurons During Fetal Development

  2003influential citation
• Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis.

  2003cites this paper
• Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling

  2003cites this paper
• Chapter 2 Pathology of Motor Neuron Disorders

  2003cites this paper
• Neuropathological analysis in spinal muscular atrophy type II

  2003cites this paper
• Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells

  2003cites this paper
• Atròfia Muscular Espinal durant el desenvolupament humà. Mecanismes de mort cel.lular i expressió de gens i proteïnes involucrades en la malaltia, L'

  2003cites this paper
• Identification of a Bcl-XL binding region within the ATPase domain of Apaf-1.

  2003cites this paper
• A Kluyveromyces lactis mutant in the essential gene KlLSM4 shows phenotypic markers of apoptosis.

  2003cites this paper
• Inhibition of Apoptosis by Z-VAD-fmk in SMN-depleted S2 Cells*

  2003cites this paper